| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 07/08/2004 | WO2004056727A2 Process of making chalcone derivatives |
| 07/08/2004 | US20040132619 Activity; crop compatibility; broad spectrum; cereals |
| 07/08/2004 | US20040131551 Chelate compounds; magnetic resonance imaging |
| 07/08/2004 | DE19744003B4 Kontrastmittel für das Infarkt- und Nekroseimaging Contrast agents for infarction and necrosis |
| 07/08/2004 | CA2508621A1 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/07/2004 | EP1434768A1 Enhanced substrate imaging by reversible binding to a paramagnetic complex |
| 07/01/2004 | WO2002100341A3 Compounds for the treatment of metabolic disorders |
| 07/01/2004 | US20040127569 involving an overproduction of nitric oxide (NO) by inducible nitric oxide synthase (iNOS) by administering to the subject an anti-inflammatory effective amount of an inducible nitric oxide synthase selective inhibitor |
| 07/01/2004 | US20040127560 compounds with high binding affinity for the glucagon receptor, such as: 3-{4-[1-(4-cyclohexylphenyl)-3-(3-trifluoromethoxyphenyl)ureidomethyl]benzoylamino}propionic acid; antidiabetic agents; antiobesity agent; antihypertensive agent |
| 07/01/2004 | US20040127533 Sulfonamide derivatives |
| 07/01/2004 | US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome |
| 06/30/2004 | EP1082299B1 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments |
| 06/30/2004 | EP1037880B1 Retinoic acid mimetic anilides |
| 06/30/2004 | CN1509285A Substituted aryl ketons |
| 06/30/2004 | CN1509269A 磺酰胺衍生物 Sulfonamide derivatives |
| 06/30/2004 | CN1155584C Process for preparation of 1,4,7,10-tetraazacyclododecane |
| 06/30/2004 | CN1155583C Method of producing tricyclene |
| 06/29/2004 | US6756391 Antiviral compounds |
| 06/29/2004 | US6756216 Batch processing using nucleophilic compound |
| 06/24/2004 | WO2004052840A1 Compounds which modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | US20040122091 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 06/24/2004 | US20040122050 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 06/24/2004 | US20040121995 such as trifluoromethanesulfonic acid, N-[4-(2,5-difluorophenyl)-4-(6-trifluoromethyl-pyridine-3-sulfonyl)-cyclohexyl]-amide; for treatment/prevention of Alzheimer's disease |
| 06/24/2004 | CA2506732A1 Compounds which modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/23/2004 | EP1430036A1 Novel method of preparing nitrogen macrocycles |
| 06/23/2004 | EP1429783A2 Multi-use multimodal imaging chelates |
| 06/23/2004 | EP1429777A1 Ophthalmologic treatment methods using selective inos inhibitors |
| 06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
| 06/23/2004 | EP1429763A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 06/23/2004 | EP1429752A1 Neuroprotective treatment methods using selective inos inhibitors |
| 06/23/2004 | EP0983251B1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof |
| 06/23/2004 | CN1507436A Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
| 06/23/2004 | CN1154647C Imidazonephthyridines and their use in inducing cytokine biosynthesis |
| 06/23/2004 | CN1154641C Anti-cancer medicine 3,6-dimethyl 1,4-dihydro 1,2,4,5-tetrazine-1,4-dimethyl amides compound and preparation process thereof |
| 06/23/2004 | CN1154489C Heterocyclic vinylethers against neurological disorders |
| 06/22/2004 | US6753429 1,4-disubstituted benzenes as insecticides |
| 06/17/2004 | WO2004050643A2 Non-nucleoside reverse transcriptase inhibitors |
| 06/17/2004 | WO2004014316A3 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 06/17/2004 | WO2003097050A3 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases |
| 06/17/2004 | US20040116483 Glucagon antagonists/inverse agonists |
| 06/17/2004 | US20040116423 5-Aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/17/2004 | US20040116404 Sulphones which modulate the action of gamma secretase |
| 06/16/2004 | EP1428532A1 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 06/16/2004 | CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds |
| 06/10/2004 | WO2004048309A1 Vitamin d receptor modulators |
| 06/09/2004 | EP1426371A1 Tetrazoyl oxime derivative and agricultural chemical containing the same as active ingredient |
| 06/09/2004 | EP1426046A1 Novel use of tricyclic compound |
| 06/09/2004 | EP1425258A2 Hydroxyeicosenoic acid analogs |
| 06/09/2004 | EP1148875B1 Methods and compositions to enhance white blood cell count |
| 06/09/2004 | CN1502611A Novel DIAR compound |
| 06/09/2004 | CN1152950C Metal ligand-contg. bleaching compositions |
| 06/08/2004 | US6747040 Imidazonaphthyridines |
| 06/03/2004 | WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 06/03/2004 | WO2004046090A2 Aryl ureido derivatives and their medical use |
| 06/03/2004 | WO2004012726A3 Methods for treatment and prevention of gastrointestinal conditions |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication |
| 06/03/2004 | CA2502705A1 Aryl ureido derivatives and their medical use |
| 06/01/2004 | US6743784 Triarylethanes for treating symptoms, diseases and conditions in extra-reproductive tract tissues, such as osteopenia, that are responsive to treatment with estrogen |
| 05/27/2004 | WO2003073986A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/27/2004 | US20040102635 Herbicides for combating weeds, preparation by mixing with extenders, surfactants; a tetrazolinone benzoyl with cyclohexyl-, isoxazole-, pyrazole-, or oxomethylene-derivatives |
| 05/27/2004 | US20040102428 Chemokine receptor binding heterocyclic compounds |
| 05/26/2004 | EP1005445B1 N-alkanoylphenylalanine derivatives |
| 05/25/2004 | CA2048172C Substituted sulfonamids, preparation processes and drugs containing same |
| 05/20/2004 | US20040097585 4-(2,6-difluorophenyl)-4-oxobutyric acid and derivatives; milder side effects; insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis, arteriosclerosis |
| 05/20/2004 | US20040097403 Linkable sialyl lewis x analogs |
| 05/19/2004 | EP1420011A1 Compounds usefulfor treating allergic and inflammatory diseases |
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | CN1496740A Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |
| 05/19/2004 | CN1496739A Application of probuco monoester in treating angiocardiopathy and inflammatory disease |
| 05/13/2004 | WO2004039762A1 Phenethanolamine derivatives for the treatment of respiratory diseases |
| 05/13/2004 | WO2004039753A2 Phenyl compounds |
| 05/13/2004 | WO2004022529A3 Diarylurea derivatives and their use as chloride channel blockers |
| 05/13/2004 | US20040092742 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 05/13/2004 | US20040092596 2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders |
| 05/13/2004 | US20040092553 Excitatory amino acid receptor modulators |
| 05/13/2004 | US20040092518 Compounds for the treatment of metabolic disorders |
| 05/13/2004 | US20040092516 Insulin resistance; antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 05/13/2004 | US20040091426 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 05/12/2004 | EP1417169A2 Selective estrogen receptor modulators |
| 05/12/2004 | EP1311485A4 Processes for preparing cilostazol |
| 05/12/2004 | EP1028111B1 Amide derivatives or salts thereof |
| 05/12/2004 | CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy |
| 05/12/2004 | CN1149204C 1-heterocycle substd. diarylamines |
| 05/12/2004 | CN1149085C Inhibition of RAF kinase using substituted heterocyclic useas |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087653 Methods for the treatment of respiratory diseases and conditions with a selective iNOS inhibitor and a PDE inhibitor and compositions therefor |
| 05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |
| 05/06/2004 | EP0998476B1 1,4,7,10-tetraazabicyclo 8.2.2]tetradecan-2-one, a process for the preparation thereof and the use thereof for the preparation of tetraazamacrocycles |
| 05/05/2004 | CN1148360C Intermediate for preparing cascade polymeric ligand usable as contrast medium |
| 05/05/2004 | CN1148346C Hydrazine derivs. |
| 04/29/2004 | WO2004035552A1 Alpha-phenyl acetanilide derivatives having an acat inhibiting activity and the therapeutic application thereof |
| 04/29/2004 | US20040082571 Substituted piperazines |
| 04/29/2004 | CA2502505A1 Alpha-phenyl acetanilide derivatives and their human therapeutic application |
| 04/28/2004 | EP1412515A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 04/28/2004 | CN1147466C Amide compounds, its prepn. method and application |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |